drugset / Trial / NCT01546896
Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
RandomizedParallel-groupSingle-blindTreatment
Summary
This research aims to investigate the efficacy and safety of buspirone in treating generalized anxiety disorder with depressive symptoms and to evaluate its neuroprotective effects using magnetic resonance imaging.
Timeline
- Start
- 2012-03
- Primary completion
- 2014-02
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alprazolam | Small molecule | 0.5 mg | — |
| Subject | Buspirone | Small molecule | 20 mg | — |
| Subject | Buspirone | Small molecule | 30 mg | — |